ACETAMINOPHEN AND IBUPROFEN Drug Patent Profile
Which patents cover Acetaminophen And Ibuprofen, and what generic alternatives are available?
Acetaminophen And Ibuprofen is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Dr Reddys, Glenmark Pharms Ltd, Granules, L Perrigo Co, Lnk Intl Inc, Pharmazone, Strides Pharma, and Taro. and is included in ten NDAs.
The generic ingredient in ACETAMINOPHEN AND IBUPROFEN is acetaminophen; ibuprofen. There is one drug master file entry for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Ibuprofen
A generic version of ACETAMINOPHEN AND IBUPROFEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN AND IBUPROFEN?
- What are the global sales for ACETAMINOPHEN AND IBUPROFEN?
- What is Average Wholesale Price for ACETAMINOPHEN AND IBUPROFEN?
Summary for ACETAMINOPHEN AND IBUPROFEN
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 47 |
| Clinical Trials: | 275 |
| Patent Applications: | 73 |
| DailyMed Link: | ACETAMINOPHEN AND IBUPROFEN at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN AND IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brigham and Women's Hospital | PHASE1 |
| National Institutes of Health (NIH) | PHASE1 |
| AFT Pharmaceuticals, Ltd. | PHASE3 |
Pharmacology for ACETAMINOPHEN AND IBUPROFEN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
